About Avidicure
Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Oegstgeest, The Netherlands
Year Founded
2022
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
avidicure.com
Domain Registered Date
Apr 20, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $50,000,000 · Seed
fundraisingfox.com
- Milestone
Website domain registered
avidicure.com
- Milestone
Company founded
Oegstgeest, The Netherlands
Investors & Backers
BioGeneration Ventures
BOM
Curie Capital
EQT Life Sciences
Kurma Partners
V-Bio Ventures
Funding History
Seed
· Jun 6, 2025
$50,000,000 fundraisingfox.com
Founders & Leadership
Arthur Lahr
Chief Executive Officer
Work email & phone locked
Unlock →
Dirk Naeyer
Chief Operating Officer
Work email & phone locked
Unlock →
Govert Schouten
Founder
Work email & phone locked
Unlock →
Oliver Nussbaumer
Senior Vice President
Work email & phone locked
Unlock →
Robert Friesen
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026